Business Segments China Isotope & Radiation Corporation
Stocks
1763
CNE1000031F4
Medical Equipment, Supplies & Distribution
|
Market Closed -
Hong Kong S.E.
09:08:03 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 15.30 HKD | -2.61% |
|
-10.11% | -24.26% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Gross Profit: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Nuclear Medicines | 3.76B | 3.93B | 4.13B | 4.17B | 4.02B | |||||
Gross Profit | 2.7B | 2.82B | 2.89B | 2.92B | 2.82B | |||||
| - | - | - | - | 333K | ||||||
Medical Laboratory Services | ||||||||||
Other Businesses | - | - | 816M | 1.31B | 1.6B | |||||
Gross Profit | - | - | 84.56M | 139M | 141M | |||||
Independent Clinical Medical and Laboratory Services and Other Businesses (Excluding Radiation Therapy Equipments and Related Services) | 338M | 754M | - | - | - | |||||
Gross Profit | 136M | 273M | - | - | - | |||||
| - | - | - | - | 24.66M | ||||||
Independent Clinical Medical and Laboratory Services and Other Businesses | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Medical Consumables | ||||||||||
Radioactive Sources and Application | 555M | 618M | 638M | 746M | 836M | |||||
Gross Profit | 232M | 283M | 276M | 319M | 420M | |||||
| - | - | - | - | 30.96M | ||||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Nuclear Medical Equipment and Related Services | 404M | 740M | 941M | 1.23B | 602M | |||||
Gross Profit | 127M | 144M | 167M | 223M | 156M | |||||
| - | - | - | - | 221K | ||||||
Healthcare Referral Services | ||||||||||
Irradiation Application | 144M | 165M | 179M | 200M | 191M | |||||
Gross Profit | 73.75M | 85.06M | 91.43M | 102M | 107M | |||||
| - | - | - | - | 6.64M | ||||||
Elimination of Inter-Segment | -52.36M | -56.49M | -71.1M | -79.67M | -62.82M | |||||
Gross Profit | -23.36M | -92.83M | -30.34M | -19.69M | -22.43M |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
People's Republic of China (PRC) | 5.14B | 6.15B | 6.63B | 7.57B | 7.19B | |||||
Total Assets | 10.47B | 11.69B | 13.19B | 14.77B | 15.72B | |||||
Interest Expense | -34.04M | -32.72M | -34.83M | -47.2M | -64.05M | |||||
Income Tax Expense | 130M | 166M | 146M | 166M | 340M | |||||
D&A | 191M | 213M | 255M | 235M | 255M | |||||
CAPEX | -428M | -534M | -898M | -1.03B | -567M | |||||
Gross Profit | 3.24B | 3.51B | 3.48B | 3.68B | 3.62B | |||||
Net Income | 336M | 392M | 371M | 407M | 327M | |||||
EBT | 803M | 921M | 922M | 1.05B | 1B | |||||
Operating Income | 778M | 913M | 942M | 1.09B | 1.06B |
Select your edition
All financial news and data tailored to specific country editions
